T3 Beta-AT Injection belongs to the class of 'anti-malarial drugs', primarily used to treat malaria. Malaria is a disease caused by a plasmodium parasite, transmitted by the bite of infected Anopheles mosquitoes. When an infected mosquito bites a healthy person, it transmits the 'Plasmodium parasite' into the bloodstream, which affects the red blood cells and liver cells. Malaria symptoms usually start 10 days to 4 weeks after the infection. They include chills, high fever, profuse sweating, headache, nausea, vomiting, abdominal pain, diarrhea, anemia, muscle pain, convulsions, coma, and bloody stools.

T3 Beta-AT Injection contains ‘Artesunate’. This T3 Beta-AT Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. T3 Beta-AT Injection is used to treat malaria caused by a parasite called 'Plasmodium falciparum,' another plasmodium species.  It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.

T3 Beta-AT Injection will be administered by a healthcare professional; do not self-administer. You may experience dizziness, headache, weakness, and loss of appetite (not feeling hungry). Most of these side effects of T3 Beta-AT Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Before using T3 Beta-AT Injection, inform your doctor if you recently used any prescription and non-prescription medications, including other anti-malarial or antibiotic drugs. Let your doctor know if you are allergic to T3 Beta-AT Injection or its components. Inform your doctor if you have any liver or kidney problems. It is essential to let your doctor know if you are pregnant, planning to conceive, or are a breastfeeding mother. T3 Beta-AT Injection causes drowsiness and dizziness it is advisable to avoid driving unless you are alert.

T3 Beta-AT Injection contains ‘Artesunate’. This T3 Beta-AT Injection is antimalarial medicine that interferes with the plasmodium parasite's growth in the red blood cells of the human body. It is used to treat cerebral malaria and all kind of severe malaria. The antimalarial effect of T3 Beta-AT Injection is commonly identified as generally safe, highly efficient and well-tolerated. T3 Beta-AT Injection is used to treat malaria caused by a parasite called 'Plasmodium falciparum,' other plasmodium species.  It works by forming harmful chemicals within the malarial parasite, therefore killing the parasites.

Inform your doctor if you have any allergic reactions to T3 Beta-AT Injection or its components. Brief your medical history to the doctor if you have any liver or kidney problems, or heart disease. Blood problems may occur after you receive treatment with this T3 Beta-AT Injection. Inform your doctor immediately if you or your child have pain in the leg, back, or stomach, chills, bleeding gums, difficulty breathing, dark urine, general body swelling, fever, loss of appetite (feeling not hungry), headache, nosebleeds, nausea, or vomiting, sore throat, pale skin, unusual tiredness or weakness, or yellow skin or eyes. Inform your doctor immediately if you or your child have chest tightness, blurred vision, cough, confusion, faintness, dizziness, or lightheadedness. When getting up unexpectedly from a sitting or lying position, skin rash, redness of the skin, itching, sweating, swelling of your face, hands, or mouth, trouble breathing or swallowing, or unusual weakness or tiredness after you receive this T3 Beta-AT Injection. It is essential to let your doctor know if you are pregnant, planning to conceive, or are a breastfeeding mother. T3 Beta-AT Injection causes drowsiness and dizziness it is advisable to avoid driving unless you are alert.